Skip to main content
Vita 34 AG logo

Vita 34 AG — Investor Relations & Filings

Ticker · V3V ISIN · DE000A0BL849 LEI · 529900OEWA4GSZEZ4P40 F Human health and social work activities
Open in API
Filings indexed 794 across all filing types
Latest filing 2014-01-22 Declaration of Voting R…
Country DE Germany
Listing F V3V

About Vita 34 AG

https://www.vita34.de/en/

Vita 34 AG is a biobank specializing in the cryopreservation of stem cells derived from umbilical cord blood and tissue. Established in 1997 as the first private cord blood bank in Europe, the company offers services for the long-term storage of perinatal stem cells for potential future medical applications. The service portfolio includes providing collection kits for childbirth, handling logistics, processing the biological material, and storing the stem cell deposits under cryogenic conditions. These services are offered to expectant parents as a form of private medical provision for their child and family. As part of the Famicord Group, Vita 34 is also involved in research and development related to cell-based therapies.

Recent filings

Filing Released Lang Actions
Declaration of Voting Results & Voting Rights Announcements 2014
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document explicitly states 'Voting Rights Announcements' in the header and details a notification from SBF Sächsische Beteiligungsfonds GmbH regarding their voting rights falling below a threshold (Article 21, Section 1 of the WpHG). This directly corresponds to the definition of 'Declaration of Voting Results & Voting Rights Announcements'. The document is short and contains the announcement itself, not just a notice about a report.
2014-01-22 English
Vita 34 AG pursues growth strategy by taking over the majority stake in Stellacure
M&A Activity Classification · 98% confidence The document text describes a corporate action where Vita 34 AG is taking over a majority stake in Stellacure GmbH as part of its growth strategy. This involves an investment and acquisition of shares. This type of announcement, detailing a significant transaction like a merger or takeover bid, aligns best with the 'M&A Activity' category (TAR). Although it is a news release format, the core content is about a transaction, not just a general regulatory update (RNS) or a report announcement (RPA). Since the definition for TAR is 'Announcements and documents related to merger proposals or takeover bids,' this classification is appropriate.
2014-01-07 English
Vita 34 AG treibt mit Mehrheitsbeteiligung an Stellacure die Wachstumsstrategie weiter voran
M&A Activity Classification · 99% confidence The document is a news release dated January 7, 2014, announcing that Vita 34 AG is acquiring a majority stake (75.24%) in Stellacure GmbH. The keywords used are 'Beteiligung/Unternehmensbeteiligung' (Participation/Corporate Acquisition) and the content details the acquisition of a competitor to strengthen market leadership. This type of announcement, detailing a merger or acquisition proposal/completion, aligns directly with the definition for M&A Activity (TAR). It is not a full annual report (10-K), an earnings release (ER), or a general regulatory filing (RNS), as it describes a specific corporate transaction.
2014-01-07 German
DGAP-DD: Vita 34 AG english
Director's Dealing Classification · 100% confidence The document text explicitly contains the header "Directors’ Dealings" and details a transaction (Purchase) made by a person in a managerial position ("Dr. Hans-Georg Giering, Position: Member of an administrative or supervisory body"). This directly corresponds to the definition of Director's Dealing, which is classified under the code DIRS.
2013-12-17 English
Declaration of Voting Results & Voting Rights Announcements 2013
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document text explicitly contains the title "Voting Rights Announcements" and discusses the notification of voting rights thresholds being exceeded by a shareholder (HSCI) in Vita 34 AG, referencing Article 26, Section 1 of the WpHG. This directly corresponds to the definition of 'Declaration of Voting Results & Voting Rights Announcements'. The document is a formal announcement regarding voting rights changes.
2013-11-25 English
Declaration of Voting Results & Voting Rights Announcements 2013
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled 'Voting Rights Announcements' and explicitly states that HSCI OJSC informed Vita 34 AG that its Voting Rights exceeded the 15% threshold on November 20, 2013, amounting to 17.14%. This directly corresponds to the definition of 'Declaration of Voting Results & Voting Rights Announcements' (Code: DVA), which covers official results from shareholder votes or announcements regarding voting rights changes crossing thresholds.
2013-11-22 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.